Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 1
1951 2
1958 1
1960 1
1963 1
1965 1
1966 1
1967 1
1968 1
1969 1
1970 2
1971 4
1972 6
1973 3
1975 1
1976 3
1977 3
1978 3
1979 6
1980 3
1981 6
1982 4
1984 7
1985 4
1986 3
1987 7
1988 4
1989 9
1990 19
1991 16
1992 7
1993 13
1994 12
1995 17
1996 13
1997 13
1998 12
1999 15
2000 14
2001 18
2002 18
2003 20
2004 14
2005 24
2006 19
2007 27
2008 28
2009 25
2010 42
2011 29
2012 45
2013 43
2014 57
2015 47
2016 50
2017 43
2018 61
2019 69
2020 77
2021 81
2022 89
2023 87
2024 30

Text availability

Article attribute

Article type

Publication date

Search Results

1,153 results

Results by year

Filters applied: . Clear all
Page 1
EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update.
Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, Holle JU, Hollinger N, Karadag O, Kronbichler A, Little MA, Luqmani RA, Mahr A, Merkel PA, Mohammad AJ, Monti S, Mukhtyar CB, Musial J, Price-Kuehne F, Segelmark M, Teng YKO, Terrier B, Tomasson G, Vaglio A, Vassilopoulos D, Verhoeven P, Jayne D. Hellmich B, et al. Ann Rheum Dis. 2024 Jan 2;83(1):30-47. doi: 10.1136/ard-2022-223764. Ann Rheum Dis. 2024. PMID: 36927642
BACKGROUND: Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) in 2016, several randomised clinical trials have been published that have the potential to change clinical care …
BACKGROUND: Since the publication of the EULAR recommendations for the management of antineutrophil cytoplasmic antibody (ANCA)-associated …
Treatment Guidelines in Vasculitis.
Kermani TA, Warrington KJ, Dua AB. Kermani TA, et al. Rheum Dis Clin North Am. 2022 Aug;48(3):705-724. doi: 10.1016/j.rdc.2022.03.006. Epub 2022 Jul 5. Rheum Dis Clin North Am. 2022. PMID: 35953232 Review.
The different forms are commonly classified based on the size of the blood vessel involved as large-vessel, medium-vessel, and small-vessel vasculitis. The American College of Rheumatology/Vasculitis Foundation recently published guidelines on the management of seve …
The different forms are commonly classified based on the size of the blood vessel involved as large-vessel, medium-vessel, and small-vessel …
Diagnosis and management of leukocytoclastic vasculitis.
Fraticelli P, Benfaremo D, Gabrielli A. Fraticelli P, et al. Intern Emerg Med. 2021 Jun;16(4):831-841. doi: 10.1007/s11739-021-02688-x. Epub 2021 Mar 13. Intern Emerg Med. 2021. PMID: 33713282 Free PMC article. Review.
Several medications can cause LCV, as well as infections, or malignancy. Among systemic diseases, the most frequently associated with LCV are ANCA-associated vasculitides, connective tissue diseases, cryoglobulinemic vasculitis, IgA vasculitis (formerly known …
Several medications can cause LCV, as well as infections, or malignancy. Among systemic diseases, the most frequently associated with …
2021 American College of Rheumatology/Vasculitis Foundation Guideline for the Management of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Chung SA, Langford CA, Maz M, Abril A, Gorelik M, Guyatt G, Archer AM, Conn DL, Full KA, Grayson PC, Ibarra MF, Imundo LF, Kim S, Merkel PA, Rhee RL, Seo P, Stone JH, Sule S, Sundel RP, Vitobaldi OI, Warner A, Byram K, Dua AB, Husainat N, James KE, Kalot MA, Lin YC, Springer JM, Turgunbaev M, Villa-Forte A, Turner AS, Mustafa RA. Chung SA, et al. Arthritis Rheumatol. 2021 Aug;73(8):1366-1383. doi: 10.1002/art.41773. Epub 2021 Jul 8. Arthritis Rheumatol. 2021. PMID: 34235894
This guideline provides recommendations for remission induction and maintenance therapy as well as adjunctive treatment strategies in GPA, MPA, and EGPA. ...CONCLUSION: This guideline presents the first recommendations endorsed by the American College of Rheumatology and t …
This guideline provides recommendations for remission induction and maintenance therapy as well as adjunctive treatment strategies in …
European consensus-based recommendations for diagnosis and treatment of immunoglobulin A vasculitis-the SHARE initiative.
Ozen S, Marks SD, Brogan P, Groot N, de Graeff N, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Pilkington C, Ravelli A, van Royen A, Uziel Y, Vastert B, Wulffraat N, Kamphuis S, Beresford MW. Ozen S, et al. Rheumatology (Oxford). 2019 Sep 1;58(9):1607-1616. doi: 10.1093/rheumatology/kez041. Rheumatology (Oxford). 2019. PMID: 30879080
OBJECTIVES: IgA vasculitis (IgAV, formerly known as Henoch-Schonlein purpura) is the most common cause of systemic vasculitis in childhood. ...Treatment recommendations included: the importance of appropriate analgesia and angiotensin-converting enzyme inhibi …
OBJECTIVES: IgA vasculitis (IgAV, formerly known as Henoch-Schonlein purpura) is the most common cause of systemic vasculit …
Diagnosis and management of ANCA-associated vasculitis.
Kronbichler A, Bajema IM, Bruchfeld A, Mastroianni Kirsztajn G, Stone JH. Kronbichler A, et al. Lancet. 2024 Feb 17;403(10427):683-698. doi: 10.1016/S0140-6736(23)01736-1. Lancet. 2024. PMID: 38368016 Review.
Granulomatosis with polyangiitis and microscopic polyangiitis are characterised by a necrotising vasculitis that can involve almost any organ, and have generally been studied together. ...Reductions in acute disease-related mortality have now shifted focus to long-term mor …
Granulomatosis with polyangiitis and microscopic polyangiitis are characterised by a necrotising vasculitis that can involve almost a …
Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis.
Emmi G, Bettiol A, Gelain E, Bajema IM, Berti A, Burns S, Cid MC, Cohen Tervaert JW, Cottin V, Durante E, Holle JU, Mahr AD, Del Pero MM, Marvisi C, Mills J, Moiseev S, Moosig F, Mukhtyar C, Neumann T, Olivotto I, Salvarani C, Seeliger B, Sinico RA, Taillé C, Terrier B, Venhoff N, Bertsias G, Guillevin L, Jayne DRW, Vaglio A. Emmi G, et al. Nat Rev Rheumatol. 2023 Jun;19(6):378-393. doi: 10.1038/s41584-023-00958-w. Epub 2023 May 9. Nat Rev Rheumatol. 2023. PMID: 37161084 Review.
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, characterized by asthma, eosinophilia and granulomatous or vasculitic involvement of several organs. ...Current practice relies on recommendati …
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, cha …
Management of cutaneous vasculitis.
Micheletti RG, Pagnoux C. Micheletti RG, et al. Presse Med. 2020 Oct;49(3):104033. doi: 10.1016/j.lpm.2020.104033. Epub 2020 Jul 6. Presse Med. 2020. PMID: 32645416 Review.
Cutaneous vasculitis encompasses cutaneous components of systemic vasculitides, skin-limited variants of systemic vasculitides, such as IgA vasculitis or cutaneous polyarteritis nodosa, and single-organ cutaneous vasculitis, as individualized in …
Cutaneous vasculitis encompasses cutaneous components of systemic vasculitides, skin-limited variants of systemic vascu …
ANCA-associated vasculitis-treatment standard.
Chalkia A, Jayne D. Chalkia A, et al. Nephrol Dial Transplant. 2024 May 31;39(6):944-955. doi: 10.1093/ndt/gfad237. Nephrol Dial Transplant. 2024. PMID: 37947275 Review.
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by small-vessel necrotizing inflammation, and prior to the advent of immunosuppressive therapy frequently had a fatal outcome. Treatment has transformed AAV into a relapsing/remitti …
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) are characterized by small-vessel necrotizing inflammation, and pr …
Diagnosis and management of kawasaki disease.
Saguil A, Fargo M, Grogan S. Saguil A, et al. Am Fam Physician. 2015 Mar 15;91(6):365-71. Am Fam Physician. 2015. PMID: 25822554 Free article. Review.
Kawasaki disease is an acute, systemic vasculitis that predominantly affects patients younger than five years. ...
Kawasaki disease is an acute, systemic vasculitis that predominantly affects patients younger than five years. ...
1,153 results